DyNAMic Discussions, Season 3 Webinar: Next steps toward the implementation of Next Generation Risk Assessment
Thursday, November 14, 2024, 10:00 AM - 11:30 AM EST
Category: Partner Webinar
SPEAKERS REGISTRATION: https://us06web.zoom.us/webinar/register/4417271967766/WN_unq6caXwQzmrf-uta2kBFQ Mirjam Luijten is a senior research toxicologist at the National Institute for Public Health and the Environment (RIVM). Her research is aimed at Next-Generation Risk Assessment, i.e., the development of a better and more human-relevant system for risk assessment of chemicals. Areas of expertise include genetic toxicity and carcinogenesis, Adverse Outcome Pathways (AOPs), New approach Methodologies (NAMs), human relevance and mixtures. She has been involved as work package leader in various international projects (e.g. PARC, RISK-HUNT3R, HBM4EU, EuroMix). In addition, she is member of various committees and expert groups, such as the OECD Expert Group on Integrated Approaches to Testing and Assessment of Non-Genotoxic Carcinogens and the Genetic Toxicology Technical Committee of HESI (Health and Environmental Sciences Institute). Matthias Herzler is a scientific director and unit head at the German Federal Institute for Risk Assessment (BfR). He has more than 20 years of experience as a risk assessor under various European chemicals legislations (pesticides, biocides, REACH and CLP). Dr. Herzler’s scientific interests circle around the uptake of New Approach Methodologies (NAMs) into regulatory practice. Over the past 20 years, he has been member of numerous EU, OECD, WHO and UN expert groups in the field, in addition to providing regulatory advice to the EU Horizon 2020 projects EU-ToxRisk and RISK-HUNT3R. At present, Dr. Herzler and his unit are deeply engaged in transversal activities under the European PARC Partnership. They are also part of the consortium of the Horizon2020 project PANORAMIX. About DyNAMic Discussions: Regulatory Toxicology has reached a tipping point – animal tests are increasingly outmoded by New Approach Methodologies (NAMs) that offer the potential to improve human health and environmental protection. So why is the transition out of animal testing and into a NAM-based approach to Chemical Safety Assessment predicted to take so long by so many commentators? And what can we collectively do to accelerate this transition? This seminar series explores these questions by inviting speakers to share candid perspectives on how they’ve overcome barriers to apply NAMs in their fields and discuss how we can learn from these examples to increase NAM use together. Each presentation if approximately 30 minutes followed by an audience led Q&A. You can watch the webinar recording by following the link below. And be sure to stay tuned for updates on the next DyNAMic Discussions webinar! This series is moderated by Eryn Slankster-Schmierer, PhD, Physicians Committee for Responsible Medicine, Kristie Sullivan, MPH, Institute for In Vitro Sciences, and Gavin Maxwell, PhD, Unilever. Learn more at: https://pcrm.org/Dynamic Contact: [email protected] |